Delcath — Clinical Research

Trial Enrollment Information

We are planning several new clinical trials, but are not currently enrolling patients for ongoing or new clinical trials at this time. Check this space often for updates.

Ongoing Clinical Trials

At present, we have one ongoing phase 2 clinical trial. This trial is closed to new enrollment.

Phase 2 Trial

This study was a phase 2 trial in which patients with unresectable cancers confined to the liver received treatments with melphalan via the Delcath System.

See Ongoing Clinical Trials

Completed Clinical Trials

Recently completed clinical trials are those that have passed the active data collection and treatment stage, but have not yet been published.

Treatment of Metastatic Melanoma in the Liver (Ocular and Cutaneous) With Melphalan

See Completed Clinical Trials

Clinical Bibliography

Browse our library of publications and abstracts

Pingpank JF, Libutti SK, Chang R, et al. Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol. 2005;23:3465-3474

Seidel GD, Locklin J, Muehlbauer PM. Part I: regional chemotherapy clinical studies in nontraditional clinical settings. Clin J Oncol Nurs. 2006;10:338-344

See the Full Clinical Bibliography

Disclaimer

Disclaimer: Delcath does not make any claim whatsoever, real or implied, about the efficacy or safety of any therapy, drug, system, or technique under active research.

Our Clinical Research Program